ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,822,000 | +0.7% | 90,000 | 0.0% | 1.96% | +10.1% |
| Q3 2016 | $1,809,000 | +51.5% | 90,000 | 0.0% | 1.78% | +43.8% |
| Q2 2016 | $1,194,000 | -28.5% | 90,000 | 0.0% | 1.24% | -14.7% |
| Q1 2016 | $1,670,000 | +1.3% | 90,000 | 0.0% | 1.45% | +45.4% |
| Q4 2015 | $1,649,000 | -88.5% | 90,000 | -88.9% | 1.00% | -72.9% |
| Q3 2015 | $14,357,000 | +2.0% | 811,152 | 0.0% | 3.68% | -7.3% |
| Q2 2015 | $14,070,000 | +9.0% | 811,152 | 0.0% | 3.97% | +33.5% |
| Q1 2015 | $12,911,000 | – | 811,152 | – | 2.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |